0
LDTs help address unmet diagnostic needs for rare diseases.
Regulatory changes now allow laboratories to operate under CLIA for LDTs.
LDTs provide faster diagnosis capabilities than traditional IVDs.
Developing LDTs can significantly reduce costs.
Strategic partnerships enhance resource access for labs.
Labs need to focus on quality and patient outcomes in test development.
Advanced technology democratizes access to sophisticated testing.
